Table 2.
Clinical data on admission of patients according to sUA levels.
| Clinical data | sUA normal (n = 460) | Hyperuricemia (n = 251) | P |
|---|---|---|---|
| WBC, 109/L (mean ± SD) | 7.2 ± 3.2 | 7.5 ± 3.2 | 0.252 |
| Hemoglobin, g/L (mean ± SD) | 119.3 ± 19.2 | 113.9 ± 21.6 | 0.001 |
| Platelets, 109/L (mean ± SD) | 188.7 ± 64.2 | 179.0 ± 64.0 | 0.058 |
| Fasting glucose, mmol/l (median, IQR) | 5.9 (4.8–7.6) | 5.6 (4.8–6.7) | 0.284 |
| HbA1C, % (median, IQR) | 6.3 (5.7–6.9) | 6.1 (5.6–6.7) | 0.313 |
| ALT, U/l (median, IQR) | 18.8 (12.8–31.8) | 18.8 (12.7–33.3) | 0.948 |
| AST, U/l (median, IQR) | 22.9 (17.3–53.2) | 22.3 (18.1–37.0) | 0.955 |
| Albumin, g/l (mean ± SD) | 35.1 ± 4.0 | 35.0 ± 4.6 | 0.688 |
| Triglycerides, mmol/l (mean ± SD) | 1.6 ± 4.1 | 1.6 ± 1.1 | 0.901 |
| Total cholesterol, mmol/l (mean ± SD) | 3.9 ± 0.9 | 3.9 ± 1.1 | 0.365 |
| HDL-cholesterol, mmol/l (mean ± SD) | 1.1 ± 0.3 | 1.0 ± 0.3 | 0.019 |
| LDL-cholesterol, mmol/l (mean ± SD) | 2.3 ± 0.8 | 2.33 ± 0.9 | 0.211 |
| Creatinine, μmol/l (mean ± SD) | 96.6 ± 68.1 | 138.0 ± 106.8 | <0.001 |
| PT, s (mean ± SD) | 13.3 ± 2.5 | 14.1 ± 4.7 | 0.117 |
| APTT, s (mean ± SD) | 42.3 ± 21.9 | 36.8 ± 11.9 | 0.101 |
| CK, U/l (mean ± SD) | 350.8 ± 714.9 | 294.6 ± 524.1 | 0.561 |
| CK-Mb, U/l (mean ± SD) | 42.0 ± 102.8 | 38.4 ± 104.7 | 0.681 |
| TnT, pg/ml (median, IQR) | 20.1 (11.3–1268.5) | 46.7 (12.2–1418.3) | 0.365 |
| hs-CRP, mg/l (median, IQR) | 4.2 (1.2–23.2) | 7.0 (1.8–20.5) | 0.173 |
| NT-proBNP, pg/ml (median, IQR) | 887.3 (290.0–2656.2) | 1704.0 (536.6–5077.2) | <0.001 |
| EF, % (mean ± SD) | 54 ± 10.1 | 52 ± 11.8 | 0.072 |
sUA: serum uric acid; WBC: white blood cells; HbA1c: glycated hemoglobin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; PT: prothrombin time; APTT: activated prothrombin time; CK: creatine kinase; CK-Mb: creatine kinase Mb chain; TnT: troponin T; hs-CRP: high-sensitivity C-reactive protein; NR-proBNP: N-terminal prohormone of brain natriuretic peptide; EF: ejection fraction.